Valeant announced on Aug. 20, 2015 that it will acquire Sprout Pharmaceuticals. The announcement comes a day after Sprout won FDA approval for the first-ever drug targeting low libido in women. The female sexual dysfunction pill from Sprout Addyi (flibanserin) is being casually referred to as thOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.